Secondary Prevention of Stroke in Patients with Atrial Fibrillation: Factors Influencing the Prescription of Oral Anticoagulation at Discharge

Publisher： Karger

E-ISSN： 1421-9786|21|5-6|372-379

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.21, Iss.5-6, 2006-05, pp. : 372-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary and Secondary Stroke Prevention in Nonrheumatic Atrial Fibrillation by Oral Anticoagulation

By  

European Neurology, Vol. 50, Iss. 3, 2003-10 ,pp. : 127-135

Karger

Access to resources Recommend Favorite

Reasons Underlying Non-Adherence to and Discontinuation of Anticoagulation in Secondary Stroke Prevention among Patients with Atrial Fibrillation

By  

European Neurology, Vol. 73, Iss. 3-4, 2015-0 ,pp. : 184-191

Karger

Access to resources Recommend Favorite

Oral Anticoagulation in Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 34-41

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Prestroke Oral Anticoagulation on Severity and Outcome of Ischemic and Hemorrhagic Stroke in Patients with Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 29, Iss. 5, 2010-03 ,pp. : 476-483

Karger

Access to resources Recommend Favorite

Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?

By Stöllberger Claudia   Bastovansky Adam   Finsterer Josef  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 4, 2013-11 ,pp. : 492-494

Springer Publishing Company

Access to resources Recommend Favorite